311 related articles for article (PubMed ID: 15035568)
1. Local and systemic administration of corticosteroids in the treatment of olfactory loss.
Heilmann S; Huettenbrink KB; Hummel T
Am J Rhinol; 2004; 18(1):29-33. PubMed ID: 15035568
[TBL] [Abstract][Full Text] [Related]
2. [Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss].
Heilmann S; Just T; Göktas O; Hauswald B; Hüttenbrink KB; Hummel T
Laryngorhinootologie; 2004 Nov; 83(11):729-34. PubMed ID: 15538662
[TBL] [Abstract][Full Text] [Related]
3. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray.
Seo BS; Lee HJ; Mo JH; Lee CH; Rhee CS; Kim JW
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1000-4. PubMed ID: 19841338
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease.
Ikeda K; Sakurada T; Suzaki Y; Takasaka T
Rhinology; 1995 Sep; 33(3):162-5. PubMed ID: 8560170
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment.
Shu CH; Lee PL; Shiao AS; Chen KT; Lan MY
Laryngoscope; 2012 Apr; 122(4):747-50. PubMed ID: 22302665
[TBL] [Abstract][Full Text] [Related]
6. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract.
Hummel T; Heilmann S; Hüttenbriuk KB
Laryngoscope; 2002 Nov; 112(11):2076-80. PubMed ID: 12439184
[TBL] [Abstract][Full Text] [Related]
7. Medical therapy and smell dysfunction.
Hellings PW; Rombaux P
B-ENT; 2009; 5 Suppl 13():71-5. PubMed ID: 20084807
[TBL] [Abstract][Full Text] [Related]
8. Topical therapy in anosmia: relevance of steroid-responsiveness.
Stenner M; Vent J; Hüttenbrink KB; Hummel T; Damm M
Laryngoscope; 2008 Sep; 118(9):1681-6. PubMed ID: 18677278
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis of a conductive olfactory loss.
Seiden AM; Duncan HJ
Laryngoscope; 2001 Jan; 111(1):9-14. PubMed ID: 11192906
[TBL] [Abstract][Full Text] [Related]
10. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization).
Jankowski R; Bodino C
Rhinology; 2003 Dec; 41(4):220-30. PubMed ID: 14750349
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy.
Berlucchi M; Valetti L; Parrinello G; Nicolai P
Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1171-5. PubMed ID: 18499270
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of corticosteroid treatment in neurosensorial anosomia: a series of 62 patients].
Faulcon P; Biacabe B; Bonfils P
Ann Otolaryngol Chir Cervicofac; 2000 Dec; 117(6):374-377. PubMed ID: 11148341
[TBL] [Abstract][Full Text] [Related]
13. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
Berlucchi M; Tomenzoli D
Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
[TBL] [Abstract][Full Text] [Related]
14. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis.
Reychler G; Colbrant C; Huart C; Le Guellec S; Vecellio L; Liistro G; Rombaux P
Laryngoscope; 2015 Mar; 125(3):549-55. PubMed ID: 25224684
[TBL] [Abstract][Full Text] [Related]
15. Predictors of prognosis in patients with olfactory disturbance.
London B; Nabet B; Fisher AR; White B; Sammel MD; Doty RL
Ann Neurol; 2008 Feb; 63(2):159-66. PubMed ID: 18058814
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of mometasone furoate microemulsion in the treatment of erosive-ulcerative oral lichen planus: pilot study.
Aguirre JM; Bagán JV; Rodriguez C; Jimenez Y; Martínez-Conde R; Díaz de Rojas F; Ponte A
J Oral Pathol Med; 2004 Aug; 33(7):381-5. PubMed ID: 15250828
[TBL] [Abstract][Full Text] [Related]
17. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract.
Reden J; Mueller A; Mueller C; Konstantinidis I; Frasnelli J; Landis BN; Hummel T
Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):265-9. PubMed ID: 16549746
[TBL] [Abstract][Full Text] [Related]
18. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
19. Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis.
Passàli D; Bernstein JM; Passali FM; Damiani V; Passàli GC; Bellussi L
Arch Otolaryngol Head Neck Surg; 2003 Jun; 129(6):656-9. PubMed ID: 12810472
[TBL] [Abstract][Full Text] [Related]
20. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
